Sulforaphane Chemoprevention for Atypical Nevi Progression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current preventive measures for melanoma, such as minimizing UV radiation exposure, are insufficient for individuals with a genetic predisposition or atypical nevi, necessitating the development of effective chemoprevention strategies.
Innovation Solution
Administration of a therapeutically effective amount of sulforaphane (SFN) orally to reduce the progression of atypical nevi and prevent melanoma by inducing cell cycle arrest and apoptosis in dysplastic skin cells and melanoma cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If UV radiation protection measures are implemented, then protection from melanoma is improved, but prevention is insufficient for genetically predisposed individuals
Solution Approach 1:
The patent applies parameter changes by introducing a chemical agent (sulforaphane) that modifies the biological parameters of melanoma cells. The compound changes the cellular environment by inducing oxidative stress and activating stress response pathways, thereby transforming the protective mechanism from external physical blocking to internal biochemical modification. This allows the prevention strategy to adapt to genetically predisposed individuals who cannot rely solely on UV protection.
2Reliability
If chemoprevention agents are developed, then prevention effectiveness for high-risk individuals is improved, but safe and effective agents are needed
Solution Approach 1:
The patent converts the harmful effect of oxidative stress, which is normally associated with cellular damage and aging, into a beneficial therapeutic mechanism. Sulforaphane intentionally induces oxidative stress in melanoma cells, triggering the Nrf2 pathway and subsequent cellular responses that lead to apoptosis or growth inhibition. By controlling and modulating this harmful oxidative stress, the patent transforms it into a selective chemoprevention mechanism that targets cancer cells while sparing healthy tissues through the activation of protective stress response pathways.
Data Source
AI summary
Disclosed herein are methods and uses for preventing melanoma, reducing progression of atypical nevi, and inducing cell cycle arrest and/or apoptosis in a melanoma cell through oral and enteral administration of sulforaphane to subjects indicated to be at risk due to factor(s) such as medical history of atypical nevi, melanoma, or UV exposure. Sulforaphane can be administered orally as a safe and well-tolerated natural agent as a chemopreventive strategy in individuals with atypical melanocytic nevi.